VentriPoint Diagnostics Investor Relations Material

VentriPoint Diagnostics Ltd. is a Canadian medical device company specializing in the development and commercialization of innovative cardiac diagnostic tools. Their flagship product, the VentriPoint Medical System (VMS+), represents a significant advancement in heart imaging technology. VMS+ is designed to provide a detailed 3D visualization of the heart's structure and function without the need for magnetic resonance imaging (MRI). This system enhances ultrasound capabilities, offering a cost-effective, fast, and accurate diagnostic solution that enables the analysis of all four heart chambers, with a particular focus on the right ventricle, which is challenging to image using conventional methods. The technology's proprietary Knowledge Based Reconstruction (KBR) technology facilitates the creation of 3D heart models and calculates volumes and ejection fractions with accuracy comparable to MRI standards. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.